ICD-10-CM E26 is the diagnosis code for Hyperaldosteronism. This code falls under the section "Disorders of other endocrine glands" within Chapter 4 — Endocrine, nutritional and metabolic diseases (E00-E89). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where E26 sits in the ICD-10-CM classification helps ensure proper coding:
No, E26 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
E26 is the ICD-10-CM diagnosis code for "Hyperaldosteronism". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
E26 is located in Section E20-E35 — "Disorders of other endocrine glands" within Chapter 4 of the ICD-10-CM Tabular List.
E26 has 4 sub-code(s) that provide more specific detail: E26.0, E26.1, E26.8, E26.9.
Use E26 when the patients documented diagnosis matches "Hyperaldosteronism" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Hyperaldosteronism is E26.
No, E26 is non-billable. Use a more specific sub-code for primary diagnosis billing.
E26 is in Chapter 4 of the ICD-10-CM Tabular List.
Yes, E26 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.